Related Experiment Video
Updated: Feb 5, 2026

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
Gastrointestinal and Hepatic Toxicities of Checkpoint Inhibitors: Algorithms for Management
Shilpa Grover1, Osama E Rahma1, Nikroo Hashemi1
1From the Harvard Medical School, Boston, MA; Brigham and Women's Hospital, Boston, MA; Dana-Farber Cancer Institute, Brookline, MA.
Abstract:
Gastrointestinal toxicities are among the leading causes of immune-related adverse effects of checkpoint blockade. These adverse events can be severe enough to require interruption or withdrawal of immune checkpoint blockade therapy. Patients with immune-related adverse effects require early recognition with an evaluation to rule out alternative etiologies and effective management to minimize complications. This article reviews the gastrointestinal and hepatic toxicities of the antibodies that target immune checkpoints CTLA-4 and PD-1/PD-L1 and provides an approach to their diagnosis and management.
More Related Videos
Related Concept Videos
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Anatomy of the Gastrointestinal System
Here's a detailed walkthrough of this complex system:
Trial and Error and Algorithm
Gastrointestinal Motility Disorders
Histology of the Gastrointestinal (GI) Tract
The mucosa is sometimes called a mucous membrane due to its mucus-secreting features. This membrane is composed of epithelium, which directly interacts with ingested substances, and the lamina propria, a layer...

